← Back to opportunities

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

NHS England

Buyer Contact Info

Buyer Name: NHS England

Buyer Address: 2nd Floor, Rutland House, Runcorn, WA7 2ES, GB

Contact Name: Michelle Clarke

Contact Email: michelle.clarke6@nhs.net

Status
complete
Procedure
open
Value
1200000000.0 GBP
Published
20 Jan 2025, 15:41
Deadline
13 Sep 2024, 12:00
Contract Start
31 Mar 2025, 23:00
Contract End
31 Dec 2027, 23:59
Category
goods
CPV
33651520 - Immunoglobulins
Region
n/a
Awarded To
CSL Behring UK Ltd, Bio Products Laboratory Ltd, Takeda UK Ltd, Grifols UK Ltd., Octapharma Limited, LFB
Official Source
Open Contracts Finder

Description

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.

Linked Documents

Select a document to preview.

Opportunity Context

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "contractPeriod": {
        "endDate": "2027-12-31T23:59:59Z",
        "startDate": "2025-04-01T00:00:00+01:00"
      },
      "date": "2024-12-19T00:00:00Z",
      "datePublished": "2025-01-20T15:41:31Z",
      "documents": [
        {
          "datePublished": "2025-01-20T15:41:31Z",
          "description": "Awarded contract notice on Contracts Finder",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "1",
          "language": "en",
          "url": "https://www.contractsfinder.service.gov.uk/Notice/f50849d8-e3d7-4276-ac88-5f2c44b2218e"
        },
        {
          "description": "Framework Agreement - Redacted",
          "format": "application/pdf",
          "id": "2",
          "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/c22ad1eb-ebc6-46b1-95f2-c6ed98a88967"
        }
      ],
      "id": "ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-CFS-307073",
          "name": "CSL Behring UK Ltd"
        },
        {
          "id": "GB-CFS-307074",
          "name": "Bio Products Laboratory Ltd"
        },
        {
          "id": "GB-CFS-307075",
          "name": "Takeda UK Ltd"
        },
        {
          "id": "GB-CFS-307076",
          "name": "Grifols UK Ltd."
        },
        {
          "id": "GB-CFS-307077",
          "name": "Octapharma Limited"
        },
        {
          "id": "GB-CFS-307078",
          "name": "LFB"
        }
      ],
      "value": {
        "amount": 905187090,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-CFS-156204",
    "name": "NHS England"
  },
  "date": "2025-01-20T15:41:33Z",
  "id": "f50849d8-e3d7-4276-ac88-5f2c44b2218e-818682",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9",
  "parties": [
    {
      "address": {
        "countryName": "GB",
        "locality": "Runcorn",
        "postalCode": "WA7 2ES",
        "streetAddress": "2nd Floor, Rutland House"
      },
      "contactPoint": {
        "email": "michelle.clarke6@nhs.net",
        "name": "Michelle Clarke"
      },
      "id": "GB-CFS-156204",
      "identifier": {
        "legalName": "NHS England"
      },
      "name": "NHS England",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "streetAddress": "4 Milton Road Haywards Heath West Sussex RH16 1AH"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-CFS-307073",
      "identifier": {
        "legalName": "CSL Behring UK Ltd"
      },
      "name": "CSL Behring UK Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "streetAddress": "Dagger Lane, Elstree, Hertfordshire WD6 3BX"
      },
      "id": "GB-CFS-307074",
      "identifier": {
        "legalName": "Bio Products Laboratory Ltd"
      },
      "name": "Bio Products Laboratory Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "streetAddress": "1 Kingdom Street London W2 6BD UK"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-CFS-307075",
      "identifier": {
        "legalName": "Takeda UK Ltd"
      },
      "name": "Takeda UK Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "streetAddress": "Grifols UK Ltd, 6th Floor, One London Wall, London, EC2Y 5EB"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-CFS-307076",
      "identifier": {
        "legalName": "Grifols UK Ltd."
      },
      "name": "Grifols UK Ltd.",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "streetAddress": "Glassworks House, 32 Shudehill, Manchester, M4 1EZ"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-CFS-307077",
      "identifier": {
        "legalName": "Octapharma Limited"
      },
      "name": "Octapharma Limited",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "streetAddress": "3 avenue des Tropiques, Les Ulis 91958, France"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-CFS-307078",
      "identifier": {
        "legalName": "LFB"
      },
      "name": "LFB",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award"
  ],
  "tender": {
    "classification": {
      "description": "Immunoglobulins",
      "id": "33651520",
      "scheme": "CPV"
    },
    "contractPeriod": {
      "endDate": "2027-12-31T23:59:59Z",
      "startDate": "2025-04-01T00:00:00+01:00"
    },
    "description": "NHS Framework Agreement for Human Albumin \u0026 Normal and Anti-D Immunoglobulin\r\n\r\nOffer reference number: CM/PHS/23/5703\r\n\r\nThe period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority\u0027s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.",
    "id": "CF-2806900D0O000000rwimUAA",
    "items": [
      {
        "deliveryAddresses": [
          {
            "countryName": "United Kingdom",
            "region": "Scotland"
          },
          {
            "countryName": "United Kingdom",
            "region": "Northern Ireland"
          },
          {
            "countryName": "United Kingdom",
            "region": "England"
          }
        ],
        "id": "1"
      }
    ],
    "mainProcurementCategory": "goods",
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure (above threshold)",
    "status": "complete",
    "suitability": {
      "sme": true,
      "vcse": false
    },
    "tenderPeriod": {
      "endDate": "2024-09-13T13:00:00+01:00"
    },
    "title": "NHS Framework Agreement for Human Albumin \u0026 Normal and Anti-D Immunoglobulin",
    "value": {
      "amount": 1200000000,
      "currency": "GBP"
    }
  }
}